27.11.2014 Views

A Guide to Primary Care of People with HIV/AIDS - Canadian Public ...

A Guide to Primary Care of People with HIV/AIDS - Canadian Public ...

A Guide to Primary Care of People with HIV/AIDS - Canadian Public ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

A <strong>Guide</strong> <strong>to</strong> <strong>Primary</strong> <strong>Care</strong> <strong>of</strong> <strong>People</strong> <strong>with</strong> <strong>HIV</strong>/<strong>AIDS</strong><br />

Chapter 12: Family Planning and Pregnancy<br />

Where should prenatal exposure cases be<br />

reported?<br />

Cases <strong>of</strong> prenatal exposure should be reported <strong>to</strong> the<br />

Antiretroviral Pregnancy Registry. This registry collects<br />

anonymous observational data. The Registry can be<br />

contacted at:<br />

Antiretroviral Pregnancy Registry<br />

115 N. Third St., Suite 28401<br />

Wilming<strong>to</strong>n, NC 28401<br />

Tel: 800-258-4263<br />

FAX: 800-800-1052<br />

KEY POINTS<br />

All <strong>HIV</strong>-positive women <strong>of</strong> childbearing<br />

age should receive information about the<br />

impact <strong>of</strong> <strong>HIV</strong> on the course and outcome <strong>of</strong><br />

pregnancy, the impact <strong>of</strong> pregnancy on <strong>HIV</strong><br />

progression, and appropriate contraception<br />

<strong>to</strong> prevent unintended pregnancy.<br />

To assure early identification <strong>of</strong> pregnancy<br />

in women <strong>with</strong> <strong>HIV</strong> who are sexually active,<br />

pregnancy tests should be done whenever<br />

they have late or missed menses or other<br />

signs <strong>of</strong> possible pregnancy. Women<br />

<strong>with</strong> the potential <strong>of</strong> becoming pregnant<br />

should be tested before starting potentially<br />

tera<strong>to</strong>genic therapies such as efavirenz<br />

(EFV). Patients should be alerted on potential<br />

tera<strong>to</strong>genic effects on the fetus, and suitable<br />

contraception should be prescribed.<br />

12<br />

Contraceptive methods recommended for<br />

women <strong>with</strong> <strong>HIV</strong> include condoms, which<br />

also protect against STDs and prevent<br />

<strong>HIV</strong> transmission <strong>to</strong> their partners, and<br />

hormonal methods. The drug interactions<br />

between oral contraceptives and many<br />

drugs used in <strong>HIV</strong> disease make an<br />

additional means <strong>of</strong> contraception advisable<br />

in many cases. Spermicides and intrauterine<br />

devices are not recommended for use by<br />

<strong>HIV</strong>-infected women.<br />

<strong>HIV</strong> testing should be a routine part <strong>of</strong><br />

prenatal care for all women. <strong>HIV</strong> testing<br />

should be voluntary using the “opt out”<br />

method (the <strong>HIV</strong> test is part <strong>of</strong> routine<br />

bloodwork and the woman may opt <strong>to</strong><br />

refuse the test). Pre- and post-test <strong>HIV</strong><br />

counseling should be provided.<br />

All pregnant women infected <strong>with</strong> <strong>HIV</strong><br />

should receive antiretroviral therapy.<br />

Zidovudine monotherapy can be provided <strong>to</strong><br />

untreated pregnant women <strong>with</strong> a baseline<br />

viral load <strong>of</strong>

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!